Page last updated: 2024-08-24

aripiprazole and Agitation, Psychomotor

aripiprazole has been researched along with Agitation, Psychomotor in 53 studies

Research

Studies (53)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	26 (49.06)	29.6817
2010's	25 (47.17)	24.3611
2020's	2 (3.77)	2.80

Authors

Authors	Studies
Kim, SG; Seo, EH; Yang, HJ; Yoon, HJ	1
De Berardis, D; Di Giannantonio, M; Fornaro, M; Napoletano, C; Pettorruso, M; Vellante, F; Ventriglio, A	1
Estrada, G; Oudovenko, N; San, L; Vieta, E	1
Barde, M; Chaumette, B; Gaillard, R; Gay, O; Masson, M	1
Jajawi, S; Jayaram, MB; Ostinelli, EG; Sayal, K; Spyridi, S	1
Zun, LS	1
Bukhanovskaya, O; Dobrovolskaya, N; Estrada, G; Montañés, F; Oudovenko, N; Popov, M; San, L; Vieta, E	1
Amatniek, J; Calabrese, JR; Carson, WH; Cox, K; Hertel, P; Jin, N; Johnson, B; McQuade, RD; Nyilas, M; Perry, PP; Sanchez, R; Such, P	1
Caccia, F; Caloro, M; Cuomo, I; De Filippis, S; De Persis, S; Gentile, G; Girardi, P; Janiri, D; Kotzalidis, GD; Lionetto, L; Piazzi, G; Sciarretta, A; Simmaco, M; Simonetti, A; Telesforo, CL	1
Dowben, JS; Keller, DM; Keltner, NL; Myhre, KE	1
Charpeaud, T; Llorca, PM; Samalin, L	1
Eleméry, M; Faludi, G; Kovács, G; Szegő, A	1
Berman, RM; Hatch, A; Largay, K; Marler, SV; Nelson, JC; Sheehan, JJ; Stewart, TD	1
Gopal, S; Hough, D; Lane, R; Nuamah, I; Savitz, AJ	1
Bose, A; Citrome, L; Claxton, A; Du, Y; Ehrich, EW; Risinger, R; Silverman, BL; Stankovic, S; Zummo, J	1
Ake, T; Al-Dhaher, Z; Carbon, M; Correll, CU; David, L; Kane, JM; Kapoor, S; Krakower, S; Saito, E	1
Chaichan, W; Kittipeerachon, M	1
Chen, L; Kinon, BJ; Kollack-Walker, S; Sniadecki, J; Stauffer, VL	1
Manos, G; Marcus, RN; McQuade, RD; Oren, DA; Rappaport, SA	1
Coley, KC; Fabian, TJ; Lenze, EJ; Ruby, C; Scipio, TM	1
Kumar, R; Sachdev, PS	1
Maurer, I	1
Aman, MG; Carson, WH; Kamen, L; Manos, G; Marcus, RN; McQuade, RD; Owen, R	1
Assunção-Talbott, S; Barnes, TR; Buckley, P; Correll, CU; Eudicone, J; Kane, JM; McQuade, R; Pikalov, A; Sachs, G; Tran, QV	1
Ali, M; Assunção-Talbott, S; Carson, WH; Forbes, RA; Iwamoto, T; Nyilas, M; Pikalov, A; Robb, AS; Whitehead, R	1
Benedetti, AM; Frazee, LA; Leung, JG; Myers, N	1
Baker, RA; Docherty, JP; Eudicone, J; Mankoski, R; Marcus, RN; Mathew, S; McQuade, RD	1
Gagliardi, JP; Jiang, W; Muzyk, AJ; Revollo, JY; Rivelli, SK	1
Alsop, DC; Dazzan, P; Handley, R; Johnston, A; Kapur, S; Marques, TR; McGuire, P; Mehta, MA; O'Gorman, R; Pariante, CM; Reinders, AA; Taylor, H; Williams, S; Zelaya, FO	1
Bobmanuel, S; Davies, W; Dratcu, L; Farmer, A; George, M; Rana, T; Singh, M; Turner, M	1
Coffey, DB; John, N; Potter, PO	1
Adams, CE; Jones, H; Powney, MJ	1
Bienroth, M; Curtis, V; Debenham, M; George, M; Gonzalez, D; Jones, S; Pitsi, D	1
DeQuardo, JR	1
Engelhardt, E; Laks, J; Marinho, V; Miotto, R	1
Howland, RH	1
Ballard, C; Waite, J	1
Duane, DD	1
Andrezina, R; Carson, WH; Iwamoto, T; Josiassen, RC; Manos, G; Marcus, RN; Oren, DA; Stock, E	1
Andrezina, R; Carson, WH; Manos, G; Marcus, RN; McQuade, RD; Oren, DA; Stock, E	1
Auby, P; Marcus, RN; McQuade, RD; Oren, DA; Sack, DA; Tran-Johnson, TK	1
Auby, P; Manos, G; Marcus, RN; McQuade, RD; Oren, DA; Stock, E; Zimbroff, DL	1
Crandall, DT; Gutierrez-Esteinou, R; Lau, GS; Marcus, RN; Marder, SR; Pikalov, A; Pultz, JA; West, B	1
Citrome, LL; Crandall, DT; Currier, GW; Manos, G; McQuade, R; Oren, D; Pikalov, AA; Zimbroff, DL	1
Allen, MH; Crandall, DT; Currier, GW; Daniel, DG; Manos, G; McQuade, R; Oren, D; Pikalov, AA; Zimbroff, DL	1
Crandall, DT; Gaulin, BD; Gutierrez-Esteinou, R; Marcus, RN; McQuade, RD; Pikalov, A; Pultz, JA; Sachs, GS; Sanchez, R	1
Allen, MH; Nordstrom, K	1
Breder, CD; Forbes, A; Marcus, RN; McQuade, RD; Mintzer, JE; Swanink, R; Tune, LE	1
Thone, J	1
Citrome, L	1
Amoretti, A; Di Lorenzo, R; Fiorini, F; Forghieri, M; Genedani, S; Rigatelli, M	1
Poyurovsky, M; Weizman, A; Weizman, R	1
Sanford, M; Scott, LJ	1

Reviews

10 review(s) available for aripiprazole and Agitation, Psychomotor

Article	Year
Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation). The Cochrane database of systematic reviews, 2018, 01-08, Volume: 1 Topics: Aggression; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Haloperidol; Humans; Injections, Intramuscular; Olanzapine; Psychomotor Agitation; Randomized Controlled Trials as Topic; Tranquilizing Agents	2018
Evidence-Based Review of Pharmacotherapy for Acute Agitation. Part 1: Onset of Efficacy. The Journal of emergency medicine, 2018, Volume: 54, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Drug Therapy; Evidence-Based Practice; Haloperidol; Humans; Injections, Intramuscular; Olanzapine; Psychomotor Agitation	2018
[Efficacy of aripiprazole for the treatment of schizophrenia: what dose is required?]. L'Encephale, 2014, Volume: 40, Issue:1 Topics: Aripiprazole; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Hostility; Humans; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2014
Akathisia and second-generation antipsychotic drugs. Current opinion in psychiatry, 2009, Volume: 22, Issue:3 Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Prevalence; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Sulpiride; Thiazoles	2009
Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:7 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Haloperidol; Humans; Hypnotics and Sedatives; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2010
Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). The Cochrane database of systematic reviews, 2012, Nov-14, Volume: 11 Topics: Aggression; Antipsychotic Agents; Aripiprazole; Clopenthixol; Dystonia; Haloperidol; Humans; Lorazepam; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Sleep; Thiazoles	2012
The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. The Cochrane database of systematic reviews, 2006, Jan-25, Issue:1 Topics: Aggression; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Humans; Mental Disorders; Olanzapine; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone	2006
Managing the acutely agitated and psychotic patient. CNS spectrums, 2007, Volume: 12, Issue:10 Suppl 1 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Emergencies; Humans; Olanzapine; Piperazines; Psychomotor Agitation; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles	2007
Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:12 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Double-Blind Method; Humans; Injections, Intramuscular; Olanzapine; Piperazines; Psychomotor Agitation; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Treatment Outcome	2007
Intramuscular aripiprazole : a review of its use in the management of agitation in schizophrenia and bipolar I disorder. CNS drugs, 2008, Volume: 22, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Injections, Intramuscular; Piperazines; Psychomotor Agitation; Quinolones; Schizophrenia	2008

Trials

22 trial(s) available for aripiprazole and Agitation, Psychomotor

Article	Year
Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder. BMC psychiatry, 2017, 04-04, Volume: 17, Issue:1 Topics: Administration, Inhalation; Adolescent; Adult; Aged; Aggression; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clinical Protocols; Humans; Injections, Intramuscular; Loxapine; Male; Middle Aged; Psychomotor Agitation; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Young Adult	2017
PLACID study: A randomized trial comparing the efficacy and safety of inhaled loxapine versus intramuscular aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2018, Volume: 28, Issue:6 Topics: Administration, Inhalation; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Injections, Intramuscular; Loxapine; Male; Middle Aged; Psychiatric Status Rating Scales; Psychomotor Agitation; Schizophrenia; Single-Blind Method; Treatment Outcome; Young Adult	2018
The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal study. Journal of affective disorders, 2018, 12-01, Volume: 241 Topics: Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Conduct Disorder; Double-Blind Method; Female; Humans; Maintenance Chemotherapy; Male; Middle Aged; Psychomotor Agitation; Substance Withdrawal Syndrome; Weight Gain; Young Adult	2018
Intramuscular aripiprazole in the acute management of psychomotor agitation. Pharmacotherapy, 2013, Volume: 33, Issue:6 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Hospitals, University; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Schizophrenia; Time Factors; Treatment Outcome; Young Adult	2013
Effect of symptom severity on efficacy and safety of aripiprazole adjunctive to antidepressant monotherapy in major depressive disorder: a pooled analysis. Journal of affective disorders, 2014, Volume: 162 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Aripiprazole; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Odds Ratio; Piperazines; Psychomotor Agitation; Quinolones; Severity of Illness Index	2014
Efficacy and safety of paliperidone extended release in adolescents with schizophrenia: a randomized, double-blind study. Journal of the American Academy of Child and Adolescent Psychiatry, 2015, Volume: 54, Issue:2 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Europe; Female; Headache; Humans; India; Male; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychomotor Agitation; Schizophrenia; Severity of Illness Index; Treatment Outcome; United States; Weight Gain	2015
Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia. International clinical psychopharmacology, 2016, Volume: 31, Issue:2 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Asia; Disease Progression; Europe; Female; Hostility; Humans; Injections, Intramuscular; Male; Middle Aged; Psychiatric Status Rating Scales; Psychomotor Agitation; Recurrence; Schizophrenia; Schizophrenic Psychology; Time Factors; Treatment Outcome; United States; Young Adult	2016
Intramuscular olanzapine versus intramuscular aripiprazole for the treatment of agitation in patients with schizophrenia: A pragmatic double-blind randomized trial. Schizophrenia research, 2016, Volume: 176, Issue:2-3 Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Comparative Effectiveness Research; Double-Blind Method; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Psychomotor Agitation; Schizophrenia; Treatment Outcome; Young Adult	2016
Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:6 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Dopamine Antagonists; Double-Blind Method; Female; Hospitalization; Humans; Lorazepam; Male; Middle Aged; Olanzapine; Piperazines; Prolactin; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Schizophrenia; Schizophrenic Psychology; Time Factors; Treatment Outcome; Triglycerides; United States; Young Adult	2008
A randomized, double-blind, placebo-controlled tolerability study of intramuscular aripiprazole in acutely agitated patients with Alzheimer's, vascular, or mixed dementia. Journal of the American Medical Directors Association, 2009, Volume: 10, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Dementia, Vascular; Double-Blind Method; Drug Tolerance; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Placebos; Psychomotor Agitation; Quinolones; United States	2009
Aripiprazole prescribing patterns and side effects in elderly psychiatric inpatients. Journal of psychiatric practice, 2009, Volume: 15, Issue:2 Topics: Aged; Aged, 80 and over; Aging; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Inpatients; Male; Mental Disorders; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Quinolones; Retrospective Studies; Schizophrenia; Treatment Outcome	2009
A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 2009, Volume: 48, Issue:11 Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Child Behavior Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Irritable Mood; Male; Personality Assessment; Piperazines; Psychomotor Agitation; Quinolones; Self-Injurious Behavior; Treatment Outcome	2009
Changes in positive and negative syndrome scale-derived hostility factor in adolescents with schizophrenia treated with aripiprazole: post hoc analysis of randomized clinical trial data. Journal of child and adolescent psychopharmacology, 2010, Volume: 20, Issue:1 Topics: Administration, Oral; Adolescent; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hostility; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Schizophrenia; Schizophrenic Psychology; Syndrome; Time Factors; Treatment Outcome	2010
Effect of aripiprazole versus haloperidol on PANSS Prosocial items in early-episode patients with schizophrenia. Schizophrenia research, 2010, Volume: 120, Issue:1-3 Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Schizophrenia; Schizophrenic Psychology; Sleep Initiation and Maintenance Disorders; Social Behavior Disorders; Young Adult	2010
Acute effects of single-dose aripiprazole and haloperidol on resting cerebral blood flow (rCBF) in the human brain. Human brain mapping, 2013, Volume: 34, Issue:2 Topics: Adolescent; Adult; Algorithms; Antipsychotic Agents; Aripiprazole; Blood Pressure; Brain Mapping; Cerebrovascular Circulation; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Double-Blind Method; Female; Haloperidol; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Piperazines; Psychomotor Agitation; Quinolones; Receptors, Dopamine D2; Young Adult	2013
Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol. Psychopharmacology, 2006, Volume: 188, Issue:3 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Anti-Dyskinesia Agents; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Blood Glucose; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Schizophrenia; Time Factors; Treatment Outcome; Withholding Treatment	2006
Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study. Current medical research and opinion, 2006, Volume: 22, Issue:11 Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Multicenter Studies as Topic; Piperazines; Psychomotor Agitation; Quinolones; Schizophrenia; Treatment Outcome	2006
Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:1 Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Schizophrenia; Treatment Outcome	2007
Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2 Topics: Acute Disease; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Injections, Intramuscular; Lorazepam; Male; Nausea; Patient Dropouts; Piperazines; Psychomotor Agitation; Quinolones; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Vomiting	2007
Aripiprazole effects in patients with acute schizophrenia experiencing higher or lower agitation: a post hoc analysis of 4 randomized, placebo-controlled clinical trials. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:5 Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychomotor Agitation; Quinolones; Schizophrenia; Severity of Illness Index; Treatment Outcome	2007
Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations. Journal of psychiatric practice, 2007, Volume: 13, Issue:3 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Quinolones; Schizophrenia	2007
Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2007, Volume: 15, Issue:11 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Institutionalization; Male; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Quinolones; Severity of Illness Index; Treatment Outcome	2007

Other Studies

21 other study(ies) available for aripiprazole and Agitation, Psychomotor

Article	Year
Amisulpride withdrawal akathisia responding to aripiprazole with propranolol in first-onset psychosis: a case report. BMC psychiatry, 2022, 01-29, Volume: 22, Issue:1 Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benztropine; Female; Humans; Hyperprolactinemia; Prolactin; Propranolol; Psychomotor Agitation; Psychotic Disorders; Young Adult	2022
Case of aripiprazole long-acting-related akathisia successfully managed with carvedilol: A case report. Psychiatry and clinical neurosciences, 2021, Volume: 75, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Carvedilol; Humans; Psychomotor Agitation; Schizophrenia	2021
[Switching from antipsychotics to aripiprazole and risk of agitation]. L'Encephale, 2018, Volume: 44, Issue:1 Topics: Antipsychotic Agents; Aripiprazole; Dopamine Antagonists; Female; Humans; Psychomotor Agitation; Risk; Risperidone; Schizophrenia; Schizophrenic Psychology; Young Adult	2018
Biological perspectives: akathisia: ants in your pants. Perspectives in psychiatric care, 2013, Volume: 49, Issue:3 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Middle Aged; Piperazines; Psychomotor Agitation; Quinolones; Treatment Outcome	2013
[Emergency psychopharmacotherapy in Hungary -- preliminary data]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2014, Volume: 16, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clopenthixol; Droperidol; Drug Prescriptions; Drug Therapy, Combination; Emergency Treatment; Female; Haloperidol; Humans; Hungary; Male; Middle Aged; Olanzapine; Piperazines; Practice Patterns, Physicians'; Promethazine; Psychiatry; Psychomotor Agitation; Psychotic Disorders; Quinolones; Surveys and Questionnaires	2014
Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth. Journal of child and adolescent psychopharmacology, 2016, Volume: 26, Issue:5 Topics: Adolescent; Aripiprazole; Arousal; Benzodiazepines; Child; Cohort Studies; Female; Humans; Male; Olanzapine; Patient Outcome Assessment; Psychomotor Agitation; Quetiapine Fumarate; Risperidone; Schizophrenia, Childhood; Schizophrenic Psychology; Wakefulness	2016
Aripiprazole for the treatment of agitation in persons with dementia? Journal of the American Medical Directors Association, 2009, Volume: 10, Issue:6 Topics: Antipsychotic Agents; Aripiprazole; Dementia; Drug Labeling; Humans; Piperazines; Psychomotor Agitation; Quinolones; United States; United States Food and Drug Administration	2009
Comparison of short-acting intramuscular antipsychotic medication: impact on length of stay and cost. American journal of therapeutics, 2011, Volume: 18, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cohort Studies; Drug Costs; Female; Haloperidol; Humans; Injections, Intramuscular; Length of Stay; Male; Middle Aged; Olanzapine; Piperazines; Psychomotor Agitation; Quinolones; Retrospective Studies; Schizophrenia; Thiazoles	2011
A retrospective study exploring the effects of intramuscular aripiprazole on QTc change in agitated medically ill patients. Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:4 Topics: Aged; Aripiprazole; Cohort Studies; Female; Heart Rate; Hospitalization; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychomotor Agitation; Quinolones; Retrospective Studies	2011
A UK panel consensus on the initiation of aripiprazole for the treatment of bipolar mania. International journal of psychiatry in clinical practice, 2012, Volume: 16, Issue:4 Topics: Acute Disease; Anhedonia; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Administration Schedule; Drug Therapy, Combination; Humans; Long-Term Care; Metabolic Diseases; Patient Participation; Piperazines; Psychomotor Agitation; Quinolones; Randomized Controlled Trials as Topic; Recovery of Function; Sexual Dysfunction, Physiological; Treatment Outcome	2012
Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms. Journal of child and adolescent psychopharmacology, 2012, Volume: 22, Issue:5 Topics: Adrenergic alpha-Agonists; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Asthma; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Chest Pain; Child; Dyskinesia, Drug-Induced; Family; Female; Guanfacine; Humans; Lithium Chloride; Male; Mood Disorders; Neuropsychological Tests; Obesity; Paroxetine; Piperazines; Polypharmacy; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Agitation; Quinolones; Selective Serotonin Reuptake Inhibitors; Smoking; Social Environment	2012
Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia. Current medical research and opinion, 2013, Volume: 29, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Haloperidol; Humans; Hypnotics and Sedatives; Olanzapine; Piperazines; Psychomotor Agitation; Quinolones; Schizophrenia; Tranquilizing Agents	2013
Worsened agitation with aripiprazole: adverse effect of dopamine partial agonism? The Journal of clinical psychiatry, 2004, Volume: 65, Issue:1 Topics: Anger; Antipsychotic Agents; Aripiprazole; Chronic Disease; Humans; Male; Middle Aged; Paranoid Disorders; Piperazines; Psychomotor Agitation; Quinolones; Schizophrenia	2004
Use of aripiprazole for psychosis and agitation in dementia. International psychogeriatrics, 2006, Volume: 18, Issue:2 Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Female; Humans; Neuropsychological Tests; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Treatment Outcome	2006
Atypical antipsychotics: special formulations for acute agitation. Journal of psychosocial nursing and mental health services, 2005, Volume: 43, Issue:10 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Olanzapine; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Risperidone; Thiazoles	2005
Aripiprazole in childhood and adolescence for Tourette syndrome. Journal of child neurology, 2006, Volume: 21, Issue:4 Topics: Adolescent; Adolescent Behavior; Adult; Antipsychotic Agents; Aripiprazole; Attention; Body Weight; Child; Child Behavior; Cognition; Dose-Response Relationship, Drug; Humans; Male; Piperazines; Psychomotor Agitation; Quinolones; Tourette Syndrome; Treatment Outcome	2006
Intramuscular aripiprazole in the control of agitation. Journal of psychiatric practice, 2007, Volume: 13, Issue:3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Arousal; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Multicenter Studies as Topic; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2007
Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:9 Topics: Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Data Interpretation, Statistical; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Psychomotor Agitation; Quinolones; Severity of Illness Index; Surveys and Questionnaires	2007
Worsened agitation and confusion in schizophrenia subsequent to high-dose aripiprazole. The Journal of neuropsychiatry and clinical neurosciences, 2007,Fall, Volume: 19, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Drug Therapy, Combination; Humans; Male; Olanzapine; Piperazines; Psychomotor Agitation; Quinolones; Schizophrenia; Schizophrenic Psychology	2007
Aripiprazole: effectiveness and safety under naturalistic conditions. Experimental and clinical psychopharmacology, 2007, Volume: 15, Issue:6 Topics: Adult; Antipsychotic Agents; Anxiety; Aripiprazole; Female; Humans; Inpatients; Italy; Male; Middle Aged; Outpatients; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Quinolones; Recurrence; Retrospective Studies; Schizoid Personality Disorder; Schizophrenia, Paranoid; Schizotypal Personality Disorder; Sleep Initiation and Maintenance Disorders; Time Factors; Treatment Outcome	2007
Aripiprazole's receptor pharmacology and extrapyramidal side effects. The American journal of psychiatry, 2008, Volume: 165, Issue:3 Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Piperazines; Piperidines; Positron-Emission Tomography; Psychomotor Agitation; Quinolones; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Urea	2008